Amentum Holdings (AMTM) EBITDA Margin (2023 - 2026)

On a quarterly basis, EBITDA Margin rose 119.0% to 4.34% in Q2 2026 year-over-year; TTM through Apr 2026 was 3.71%, a 53.0% increase, with the full-year FY2025 number at 3.33%, down 13.0% from a year prior.

Amentum Holdings (AMTM) has 4 years of EBITDA Margin data on record, last reported at 4.34% in Q2 2026.

  • EBITDA Margin reached 4.34% in Q2 2026 per AMTM's latest filing, up from 4.26% in the prior quarter.
  • Over the last five years, EBITDA Margin for AMTM hit a ceiling of 4.34% in Q2 2026 and a floor of 1.22% in Q3 2024.
  • A 4-year average of 3.6% and a median of 4.01% in 2024 define the central range for EBITDA Margin.
  • On a YoY basis, EBITDA Margin climbed as much as 222bps in 2025 and fell as far as -126bps in 2025.
  • Tracing AMTM's EBITDA Margin over 4 years: stood at 4.34% in 2023, then dropped by -11bps to 3.86% in 2024, then dropped by -11bps to 3.44% in 2025, then increased by 26bps to 4.34% in 2026.
  • Business Quant data shows EBITDA Margin for AMTM at 4.34% in Q2 2026, 4.26% in Q1 2026, and 3.44% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Relx 81.40 Bn 81.16 Bn - -
2 Rentokil Initial 79.56 Bn 78.10 Bn - 7.67%
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn 23.22%
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn 34.65%
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn 18.21%
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn -0.53%
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn 17.62%
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn 4.48%
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn 4.34%
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn 28.55%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 4.34%
Jan 2, 2026 4.26%
Oct 3, 2025 3.44%
Jun 27, 2025 2.89%
Mar 28, 2025 3.15%
Dec 27, 2024 3.86%
Sep 27, 2024 1.22%
Jun 28, 2024 4.15%
Mar 29, 2024 4.34%
Dec 29, 2023 4.34%